S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.06%) $0.927
USD/NOK
(0.31%) $10.87
USD/GBP
(0.06%) $0.793
USD/RUB
(-0.31%) $92.29

Realtime updates for Rapt Therapeutics Inc [RAPT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 12.00%
SELL
0.00%
return 13.08%
Last Updated28 Mar 2024 @ 16:00

0.56% $ 8.98

SELL 64217 min ago

@ $24.99

Issued: 13 Feb 2024 @ 15:43


Return: -64.07%


Previous signal: Feb 13 - 09:30


Previous signal: Buy


Return: 0.73 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases...

Stats
Today's Volume 608 335
Average Volume 1.26M
Market Cap 312.48M
EPS $0 ( 2024-03-12 )
Next earnings date ( $-0.800 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.94
ATR14 $0.0200 (0.22%)
Insider Trading
Date Person Action Amount type
2024-01-31 Ho William Buy 75 000 Employee Stock Option (right to buy)
2024-01-31 Young Rodney Kb Buy 90 000 Employee Stock Option (right to buy)
2024-01-31 Brockstedt Dirk G. Buy 75 000 Employee Stock Option (right to buy)
2024-01-31 Wong Brian Russell Buy 275 000 Employee Stock Option (right to buy)
2024-01-05 Brockstedt Dirk G. Sell 898 Common Stock
INSIDER POWER
94.29
Last 100 transactions
Buy: 3 717 989 | Sell: 63 895

Volume Correlation

Long: 0.44 (neutral)
Short: 0.72 (moderate)
Signal:(58.237) Neutral

Rapt Therapeutics Inc Correlation

10 Most Positive Correlations
RDUS0.903
ICON0.901
ATCX0.9
SYKE0.898
PAE0.889
BRACU0.886
RCON0.884
CLBT0.884
ABNB0.878
DKNG0.876
10 Most Negative Correlations
VIEW-0.886
SBBP-0.863
TUEM-0.855
LGHL-0.855
ARDS-0.848
LCAP-0.844
RPTX-0.839
AHPI-0.839
MTEX-0.838
NAKD-0.838

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Rapt Therapeutics Inc Correlation - Currency/Commodity

The country flag -0.66
( moderate negative )
The country flag -0.59
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.25
( neutral )
The country flag -0.65
( moderate negative )
The country flag -0.39
( neutral )

Rapt Therapeutics Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-3.55M (0.00 %)
EPS: $-3.05
Q4 2023
Revenue: $0
Gross Profit: $-323 000 (0.00 %)
EPS: $-0.800
Q3 2023
Revenue: $0
Gross Profit: $-908 000 (0.00 %)
EPS: $-0.820
Q2 2023
Revenue: $0
Gross Profit: $-853 000 (0.00 %)
EPS: $-0.660

Financial Reports:

No articles found.

Rapt Therapeutics Inc

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators